← Back to headlines
Axsome Therapeutics Beats EPS and Revenue Estimates
Axsome Therapeutics reported GAAP EPS of -$0.56, beating estimates by $0.13, and revenue of $195.99M, surpassing estimates by $2.73M.
23 Feb, 12:04 — 23 Feb, 12:04
ℹOnly 1 source covers this story
